Case Report
BibTex RIS Cite

Ketiapine Bağlı Geri Dönüşlü Deri Döküntüsü: Bir Olgu Sunumu

Year 2023, Volume: 2 Issue: 3, 141 - 146, 30.11.2023
https://doi.org/10.59312/ebshealth.1329032

Abstract

Çeşitli psikiyatrik bozuklukların tedavisinde kullanılan ketiapin deri döküntüsüne neden olabilir. Bu olgu sunumunda, ketiapin kullanımı ile ilişkili deri döküntüsünü sunduk. Yaygın anksiyete bozukluğu tanısıyla takip edilen ve uykusuzluk şikâyetine yönelik olarak ketiapin 200 mg/gün başlanan 43 yaşındaki erkek hastada tedavinin yedinci gününde yüz, saçlı deri ve boyun bölgesiyle sınırlı deri döküntüsü ortaya çıktı. İlaç başlanmasınu takiben ortaya çıkan bu yan etki ketiapin kullanımı ile ilişkilendirildi ve ilaç kesildi. Ketiapin kesilmesini takiben deri döküntüsü giderek azaldı ve üç haftanın sonunda tamamen ortadan kayboldu. Hastanın yaygın anksiyete bozukluğu ile ilişkili tedavisi tamamlandı ve taburcu edildi. Takiplerinde deri döküntüsü gözlenmedi. Deri ile ilişkili yan etkiler ketiapin kullanımı ile ilişkili olabilir. Klinisyenler, ketiapinin deri döküntüsü yan etkisine karşı uyanık olmalıdır.

References

  • Rowe, D.L. (2007). Off-label prescription of quetiapine in psychiatric disorders. Expert Review of Neurotherapeutics 7(7), 841-852.
  • Joshi, M., Kumar, S. (2023). Allergic cutaneous drug eruptions with quetiapine: a case study. Indian Journal of Psychological Medicine, 45(4), 441-442.
  • Kose, S., Akin, E., Cetin, M. (2017). Adverse drug reactions and causality: The Turkish version of naranjo adverse drug reactions probability scale. Psychiatry and Clinical Psychopharmacology, 27(2), 205-206.
  • Edwards, I.R., Biriell, C. (1994). Harmonisation in pharmacovigilance. Drug Safety, 10, 93-102.
  • Biju, R.A., Davis, S., Sanal, G. (2022). Quetiapine‑induced drug rash with eosinophilia and systemic symptom syndrome. Journal of Medical Sciences, 42(5), 242‑244.
  • Lasić, D., Ivanišević, R., Uglešić, B., Cvitanović, M.Z., Glučina, D., Hlevnjak, I. (2013). Acute generalized exanthematous pustulosis as a side effect of quetiapine. Psychiatria Danubina, 25(1), 84-85.
  • Ram, D., Mathur, S. (2019). Quetiapine-induced leukocytoclastic vasculitis. Indian Journal of Pharmacology, 51(4), 282-283.
  • Lin, G.L., Chiu, C.H., Lin, S.K. (2006). Quetiapine-induced erythema multiforme minor: a case report. Journal of Clinical Psychopharmacology, 26(6), 668-669.

Quetiapine-Induced Reversible Skin Rash: A Case Report

Year 2023, Volume: 2 Issue: 3, 141 - 146, 30.11.2023
https://doi.org/10.59312/ebshealth.1329032

Abstract

Quetiapine, used in the treatment of various psychiatric disorders, can cause skin rash. In this case report, we presented a skin rash associated with quetiapine use. A 43-year-old male patient, who was followed up with the diagnosis of generalized anxiety disorder and was started on quetiapine 200 mg/day for insomnia, developed a skin rash limited to the face, scalp, and neck area on the seventh day of treatment. This side effect that occurred after the drug was started was associated with the use of quetiapine and the drug was discontinued. After discontinuation of quetiapine, the skin rash gradually decreased and disappeared completely after three weeks. The patient's treatment for generalized anxiety disorder was completed and he was discharged. No skin rash was observed in the follow-ups. Skin-related side effects may be associated with quetiapine use. Clinicians should be alert to the rash side effect of quetiapine.

References

  • Rowe, D.L. (2007). Off-label prescription of quetiapine in psychiatric disorders. Expert Review of Neurotherapeutics 7(7), 841-852.
  • Joshi, M., Kumar, S. (2023). Allergic cutaneous drug eruptions with quetiapine: a case study. Indian Journal of Psychological Medicine, 45(4), 441-442.
  • Kose, S., Akin, E., Cetin, M. (2017). Adverse drug reactions and causality: The Turkish version of naranjo adverse drug reactions probability scale. Psychiatry and Clinical Psychopharmacology, 27(2), 205-206.
  • Edwards, I.R., Biriell, C. (1994). Harmonisation in pharmacovigilance. Drug Safety, 10, 93-102.
  • Biju, R.A., Davis, S., Sanal, G. (2022). Quetiapine‑induced drug rash with eosinophilia and systemic symptom syndrome. Journal of Medical Sciences, 42(5), 242‑244.
  • Lasić, D., Ivanišević, R., Uglešić, B., Cvitanović, M.Z., Glučina, D., Hlevnjak, I. (2013). Acute generalized exanthematous pustulosis as a side effect of quetiapine. Psychiatria Danubina, 25(1), 84-85.
  • Ram, D., Mathur, S. (2019). Quetiapine-induced leukocytoclastic vasculitis. Indian Journal of Pharmacology, 51(4), 282-283.
  • Lin, G.L., Chiu, C.H., Lin, S.K. (2006). Quetiapine-induced erythema multiforme minor: a case report. Journal of Clinical Psychopharmacology, 26(6), 668-669.
There are 8 citations in total.

Details

Primary Language Turkish
Subjects Psychiatry
Journal Section Olgu Sunumu
Authors

Mehmet Hamdi Örüm 0000-0002-4154-0738

Dilek Örüm 0000-0001-8369-1553

Publication Date November 30, 2023
Published in Issue Year 2023 Volume: 2 Issue: 3

Cite

APA Örüm, M. H., & Örüm, D. (2023). Ketiapine Bağlı Geri Dönüşlü Deri Döküntüsü: Bir Olgu Sunumu. Doğu Karadeniz Sağlık Bilimleri Dergisi, 2(3), 141-146. https://doi.org/10.59312/ebshealth.1329032

Doğu Karadeniz Sağlık Bilimleri Dergisi - EBSHealth
Giresun Üniversitesi Sağlık Bilimleri Fakültesi © 2023

ebshealth@giresun.edu.tr

EBSHealth açık erişim politikasıyla yayın yapan bilimsel ve hakemli bir dergidir.